Can medical technology stocks continue their upwards momentum in the second half of the year? Investors say yes. But technical analysis says not necessarily.
In the first six months of 2016, the health care sub-sector has outperformed the S&P 500 by 10.2% and outperformed the S&P Healthcare Index by 13.4%, according to JPMorgan analysts.
